About Oui Therapeutics
Oui Therapeutics is a company based in New Haven (United States) founded in 2018 by Brian Keenaghan, Leng Lee, and Seth Feuerstein. Oui Therapeutics has raised $26 million across 6 funding rounds from investors including HHS, First Round Capital and CVS Health Ventures. The company has 9 employees as of December 31, 2024. Oui Therapeutics offers products and services including Digital Therapeutic for Suicide. Oui Therapeutics operates in a competitive market with competitors including Better Therapeutics, SilverCloud, Sincrolab, ieso and Waypoint Health, among others.
- Headquarter New Haven, United States
- Employees 9 as on 31 Dec, 2024
- Founders Brian Keenaghan, Leng Lee, Seth Feuerstein
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oui Therapeutics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26 M (USD)
in 6 rounds
-
Latest Funding Round
$440.09 K (USD), Grant
Jun 05, 2024
-
Investors
HHS
& 2 more
-
Employee Count
9
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oui Therapeutics
Oui Therapeutics offers a comprehensive portfolio of products and services, including Digital Therapeutic for Suicide.
Prescription-based digital tool to prevent suicide through expert-guided interventions.
People of Oui Therapeutics
Unlock access to complete
Funding Insights of Oui Therapeutics
Oui Therapeutics has successfully raised a total of $26M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $440.09 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oui Therapeutics
Oui Therapeutics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, First Round Capital and CVS Health Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused seed and early-stage VC firm
|
Locked | Locked | Locked | |
|
Venture capital investment for the healthcare industry
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Oui Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oui Therapeutics
Investment portfolio details for Oui Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oui Therapeutics
Detailed financials for Oui Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oui Therapeutics Comparisons
Peer comparison for Oui Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oui Therapeutics
Oui Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Better Therapeutics, SilverCloud, Sincrolab, ieso and Waypoint Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based cardiac therapy planning software is developed for professionals.
|
|
| Locked | Locked | Locked |
Mental health programs are delivered through a cloud-based platform.
|
|
| Locked | Locked | Locked |
Gamified software for neuropsychological rehabilitation is offered to physicians.
|
|
| Locked | Locked | Locked |
Mental health conditions are addressed through AI-powered digital CBT platform.
|
|
| Locked | Locked | Locked |
Web-based self-help programs that teach cognitive behavior therapy (CBT) skills
|
Detailed competitors of Oui Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oui Therapeutics
Complete news archive for Oui Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oui Therapeutics
Oui Therapeutics was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Oui Therapeutics is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Seth Feuerstein is the current CEO of Oui Therapeutics. They have also founded this company.
Oui Therapeutics is a funded company, having raised a total of $26M across 6 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Oui Therapeutics is 9.
Founded in 2018 and based in New Haven, United States, the company operates in the digital therapeutics sector focused on mental health. Prescription-based digital tools are developed to support suicide prevention efforts. Clinical trials are conducted to assess treatment efficacy, with collaboration involving experts in digital therapy and suicide prevention. Solutions are designed for individuals at risk, emphasizing evidence-based digital interventions.
Oui Therapeutics's top competitors include SilverCloud, ieso and Better Therapeutics.
Oui Therapeutics offers Digital Therapeutic for Suicide.
Oui Therapeutics has 3 investors. Key investors include HHS, First Round Capital, and CVS Health Ventures.